Search by Drug Name or NDC
NDC 00078-0467-91 Desferal 500 mg/1 Details
Desferal 500 mg/1
Desferal is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is DEFEROXAMINE MESYLATE.
Product Information
| NDC | 00078-0467 |
|---|---|
| Product ID | 0078-0467_1a76f5bb-28fe-4cbb-8735-2ce7b041a15e |
| Associated GPIs | 93000020102110 |
| GCN Sequence Number | 002544 |
| GCN Sequence Number Description | deferoxamine mesylate VIAL 500 MG INJECTION |
| HIC3 | C8A |
| HIC3 Description | METALLIC POISON,AGENTS TO TREAT |
| GCN | 07111 |
| HICL Sequence Number | 001104 |
| HICL Sequence Number Description | DEFEROXAMINE MESYLATE |
| Brand/Generic | Brand |
| Proprietary Name | Desferal |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | deferoxamine mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | DEFEROXAMINE MESYLATE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Iron Chelating Activity [MoA], Iron Chelator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA016267 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0467-91 (00078046791)
| NDC Package Code | 0078-0467-91 |
|---|---|
| Billing NDC | 00078046791 |
| Package | 4 VIAL in 1 CARTON (0078-0467-91) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61) |
| Marketing Start Date | 1968-04-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |